ArticleFrontiers in pharmacology2022

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway.

Xiahenazi Aiyasiding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.